Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eneda Toska

Showing results (1-10 of 53) with videos related to

Pageof 6
Sort By:
Biochimica Et Biophysica Acta. Reviews on Cancer|March 22, 2024
Epigenetic mechanisms of cancer progression and therapy resistance in estrogen-receptor (ER+) breast cancerEneda Toska
Cancer Research|October 17, 2022
A Unique FOXA1-Associated Chromatin State Dictates Therapeutic Resistance in Lobular Breast CancerRyan Blawski, Eneda Toska
Molecular & Cellular Oncology|November 7, 2019
Chromatin regulation at the intersection of estrogen receptor and PI3K pathways in breast cancerPau Castel, Eneda Toska
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 10, 2016
Pharmacology in the Era of Targeted Therapies: The Case of PI3K InhibitorsEneda Toska, José Baselga
The Journal of Pathology|September 9, 2025
Sparking malignancy: nicotine as a driver of stemness and metastasis in triple-negative breast cancer<sup>†</sup>Christopher Simpkins, Eneda Toska
Cell|June 25, 2021
Josep Baselga (1959-2021)Pau Castel, Eneda Toska
Frontiers in Oncology|July 1, 2022
Epigenetic Mechanisms Influencing Therapeutic Response in Breast CancerAmaia Arruabarrena-Aristorena, Eneda Toska
Trends in Immunology|July 27, 2024
Mutant ARID1A: igniting cancer immunotherapyBujamin H Vokshi, Eneda Toska
Molecular & Cellular Oncology|May 24, 2021
<i>FOXA1</i> mutations influence the therapeutic response of breast cancer by altering chromatin stateAmaia Arruabarrena-Aristorena, Eneda Toska
The Biochemical Journal|June 14, 2014
Mechanisms of transcriptional regulation by WT1 (Wilms' tumour 1)Eneda Toska, Stefan G E Roberts
Pageof 6

Showing results (1-10 of 53) with videos related to

Sort By:
Pageof 6
Biochimica Et Biophysica Acta. Reviews on Cancer|March 22, 2024
Epigenetic mechanisms of cancer progression and therapy resistance in estrogen-receptor (ER+) breast cancerEneda Toska
Cancer Research|October 17, 2022
A Unique FOXA1-Associated Chromatin State Dictates Therapeutic Resistance in Lobular Breast CancerRyan Blawski, Eneda Toska
Molecular & Cellular Oncology|November 7, 2019
Chromatin regulation at the intersection of estrogen receptor and PI3K pathways in breast cancerPau Castel, Eneda Toska
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 10, 2016
Pharmacology in the Era of Targeted Therapies: The Case of PI3K InhibitorsEneda Toska, José Baselga
The Journal of Pathology|September 9, 2025
Sparking malignancy: nicotine as a driver of stemness and metastasis in triple-negative breast cancer<sup>†</sup>Christopher Simpkins, Eneda Toska
Cell|June 25, 2021
Josep Baselga (1959-2021)Pau Castel, Eneda Toska
Frontiers in Oncology|July 1, 2022
Epigenetic Mechanisms Influencing Therapeutic Response in Breast CancerAmaia Arruabarrena-Aristorena, Eneda Toska
Trends in Immunology|July 27, 2024
Mutant ARID1A: igniting cancer immunotherapyBujamin H Vokshi, Eneda Toska
Molecular & Cellular Oncology|May 24, 2021
<i>FOXA1</i> mutations influence the therapeutic response of breast cancer by altering chromatin stateAmaia Arruabarrena-Aristorena, Eneda Toska
The Biochemical Journal|June 14, 2014
Mechanisms of transcriptional regulation by WT1 (Wilms' tumour 1)Eneda Toska, Stefan G E Roberts
Pageof 6